IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Atherosclerosis Plus

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

1.62

h-Index

2022-2023

 53

Rank

2022-2023

 13017

SJR

2022-2023

 0.377

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Atherosclerosis Plus
Abbreviation Atheroscler. Plus
Publication Type Journal
Subject Area, Categories, Scope Cardiology and Cardiovascular Medicine (Q3); Internal Medicine (Q3)
h-index 53
Overall Rank/Ranking 13017
SCImago Journal Rank (SJR) 0.377
Impact Score 1.62
Publisher Elsevier Ireland Ltd
Country Ireland
ISSN 26670895, 26670909
Best Quartile Q3
Coverage History 2021-2022




About Atherosclerosis Plus


Atherosclerosis Plus is a journal covering the technologies/fields/categories related to Cardiology and Cardiovascular Medicine (Q3); Internal Medicine (Q3). It is published by Elsevier Ireland Ltd. The overall rank of Atherosclerosis Plus is 13017. According to SCImago Journal Rank (SJR), this journal is ranked 0.377. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 53. The best quartile for this journal is Q3.

The ISSN of Atherosclerosis Plus journal is 26670895, 26670909. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Atherosclerosis Plus is cited by a total of 105 articles during the last 3 years (Preceding 2022).


Atherosclerosis Plus Impact IF 2022-2023


The Impact IF 2022 of Atherosclerosis Plus is 1.62, which is computed in 2023 as per its definition. Atherosclerosis Plus IF is increased by a factor of 0.06 and approximate percentage change is 3.85% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Atherosclerosis Plus Impact IF 2023 Prediction


Impact IF 2022 of Atherosclerosis Plus is 1.62. If the same upward trend persists, Impact IF may rise in 2023 as well.


Impact IF Trend


Year wise Impact IF of Atherosclerosis Plus. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 1.62
2021 1.56
2020 1.32
2019 3.08
2018 2.43
2017 3.47
2016 3.10
2015 3.71
2014 3.12

Atherosclerosis Plus h-index


  Table Setting

Atherosclerosis Plus has an h-index of 53. It means 53 articles of this journal have more than 53 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Atherosclerosis Plus ISSN


The ISSN of Atherosclerosis Plus is 26670895, 26670909. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Atherosclerosis Plus Rank and SCImago Journal Rank (SJR)


The overall rank of Atherosclerosis Plus is 13017. According to SCImago Journal Rank (SJR), this journal is ranked 0.377. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Atherosclerosis Plus by Year


Year SJR
2023/2024 Coming Soon
2022 0.377
2021 0.374
2020
2019
2018
2017
2016
2015
2014

Ranking of Atherosclerosis Plus by Year


Year Ranking
2023/2024 Coming Soon
2022 13017
2021 12691
2020 32804
2019 30369
2018 31781
2017 32522
2016 32326
2015 32008
2014 31422

Atherosclerosis Plus Publisher


Table Setting

Atherosclerosis Plus is published by Elsevier Ireland Ltd. It's publishing house is located in Ireland. Coverage history of this journal is as following: 2021-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Atherosclerosis Plus is Atheroscler. Plus. This abbreviation ('Atheroscler. Plus') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Atherosclerosis Plus


If your research field is/are related to Cardiology and Cardiovascular Medicine (Q3); Internal Medicine (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Atherosclerosis Plus?

Atherosclerosis Plus latest impact IF is 1.62. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 3.71 (2015) and 1.32 (2020), respectively, in the last 9 years. Moreover, its average IS is 2.6 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Atherosclerosis Plus?

The Atherosclerosis Plus has an SJR (SCImago Journal Rank) of 0.377, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.377 in 2022 and the lowest being in 2020. Furthermore, the average SJR of the Atherosclerosis Plus over the previous 9-year period stands at 2.6.


What's the latest h-index of the Atherosclerosis Plus?

The latest h-index of the Atherosclerosis Plus is 53.


Who's the publisher of the Atherosclerosis Plus?

The Atherosclerosis Plus is published by the Elsevier Ireland Ltd, with its country of publication being the Ireland.


What's the current ranking of the Atherosclerosis Plus?

The Atherosclerosis Plus is currently ranked 13017 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 12691 in 2021 and its lowest position of 32804 in 2020.


What's the abbreviation or short name for the Atherosclerosis Plus?

The standard ISO4 abbreviation for the Atherosclerosis Plus is Atheroscler. Plus.


Is the "Atherosclerosis Plus" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Atherosclerosis Plus is classified as a journal that the Elsevier Ireland Ltd publishes.


What's the scope or major areas of the Atherosclerosis Plus?

The Atherosclerosis Plus encompasses the following areas:

  • Cardiology and Cardiovascular Medicine
  • Internal Medicine

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Atherosclerosis Plus?

The Atherosclerosis Plus is assigned the following International Standard Serial Numbers (ISSN): 26670895, 26670909.


What's the best quartile of the Atherosclerosis Plus?

The best quartile for the Atherosclerosis Plus is Q3 (2022).


What's the coverage history of the Atherosclerosis Plus?

The Atherosclerosis Plus coverage history can be summarized as follows: 2021-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Business Strategy Review journal 31512 Wiley-Blackwell Publishing Ltd 33 0.04
Canadian Journal of Education journal 17961 Canadian Society for the Study of Education (CSSE) 41 0.39
Sex Education journal 5168 Routledge 41 2.82
Natural Solutions trade journal 28581 Innovision Health Media 1 0.00
Journal of Sociology journal 6009 SAGE Publications Ltd 58 3.21
Engenharia Agricola journal 15839 Sociedade Brasileira de Engenharia Agricola 30 1.12
Geo-Info journal 30490 Nederlandse Vereniging voor Kartografie 2 0.00
WSEAS Transactions on Environment and Development journal 17731 World Scientific and Engineering Academy and Society 23 1.33
PLoS ONE journal 5108 Public Library of Science 404 3.75
Journal on Chain and Network Science journal 11905 Wageningen Academic Publishers 24 0.00

Check complete list




Year wise Impact Score (IS) of Atherosclerosis Plus

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 1.62
2021 1.56
2020 1.32
2019 3.08
2018 2.43
2017 3.47
2016 3.10
2015 3.71
2014 3.12



Top Journals/Conferences in Cardiology and Cardiovascular Medicine

Journal of the American College of Cardiology
Elsevier USA | United States

Circulation
Lippincott Williams and Wilkins Ltd. | United States

JAMA Cardiology
American Medical Association | United States

Nature Reviews Cardiology
Nature Publishing Group | United Kingdom

European Journal of Heart Failure
Wiley-Blackwell | United States

JACC: Heart Failure
Elsevier BV | Netherlands

Circulation Research
Lippincott Williams and Wilkins Ltd. | United States

JACC: Cardiovascular Imaging
Elsevier Inc. | United States

European Heart Journal
Oxford University Press | United Kingdom

Circulation: Heart Failure
Lippincott Williams and Wilkins Ltd. | United States

See All

Top Journals/Conferences in Internal Medicine

Lancet Diabetes and Endocrinology,The
Elsevier Ltd. | United Kingdom

Lancet Regional Health - Europe, The
Elsevier Ltd. | United Kingdom

Nature Metabolism
Springer Berlin | Germany

Diabetes Care
American Diabetes Association Inc. | United States

JAMA Internal Medicine
American Medical Association | United States

Annals of Internal Medicine
American College of Physicians | United States

Diabetologia
Springer Verlag | Germany

Lancet Regional Health - Americas, The
Elsevier Ltd. | United Kingdom

Journal of Internal Medicine
Wiley-Blackwell Publishing Ltd | United Kingdom

JHEP Reports
Elsevier BV | Netherlands

See All